NCT04266353 2023-05-09
Effect of Resveratrol on Serum IGF2 Among African American Women
Loma Linda University
Phase NA Withdrawn
Clinical Trials
10 trialsNCT03253913 2023-02-01
RESULT
University of Cincinnati
Phase 2 Completed
NCT04867252 2021-09-13
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase 2 Completed
NCT01476592 2019-11-18
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
University of Wisconsin, Madison
Phase NA Completed
NCT00920556 2019-02-27
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
GlaxoSmithKline
Phase 2 Terminated
NCT02261844 2017-03-30
Resveratrol and Human Hepatocyte Function in Cancer
University of Louisville
Phase 1/2 Withdrawn
NCT00433576 2014-09-15
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00256334 2014-06-20
Resveratrol for Patients With Colon Cancer
University of California, Irvine
Phase 1 Completed
NCT00098969 2012-12-17
IRB 2004-535
National Cancer Institute (NCI)
Phase 1 Completed
NCT00455416 2008-05-21
KLYMF
Oslo University Hospital
Phase 2 Unknown